Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten

JACC Heart Failure(2024)10.1016/j.jchf.2024.03.009Source: DataRank Database

Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten is a research paper published in JACC Heart Failure (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.70)OA: greenTopics (30)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Anandkumar Dubey,Thomas Carattini ORCID,Amy Marzolf,Nicole Hornsby,Alejandro de Feria

Live enrichment

PubMed:38661589 OpenAlex:https://openalex.org/W4394063216

National Institutes of Health

Grant: K23HL166961

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: K08DK124577

FWCI

4.70

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11156526/pdf/nihms-1996414.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213177924002634?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213177924002634?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11156526

Fields of Study

Cardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsAdvanced battery technologies researchHumansCardiomyopathy, HypertrophicMaleFemaleMiddle AgedTreatment OutcomeAgedRetrospective StudiesBenzylaminesUracil

MeSH Terms

AgedBenzylaminesCardiomyopathy, HypertrophicFemaleHumansMaleMiddle AgedRetrospective StudiesUracilTreatment Outcome

Keywords

MedicineObstructive cardiomyopathyHypertrophic cardiomyopathyInternal medicineCardiologyHeart failureCardiomyopathy